Home » Topics » Pharmaceuticals » Research and Development

July 14, 2020
Merck Teams Up with Dewpoint for Novel HIV Treatment
The Boston company will receive up to $305 million in upfront and milestone payments, as well as royalties on future product sales.
July 14, 2020
Genentech’s Tecentriq-Avastin Combo Flops in Ovarian Cancer Trial
The company said the treatment did not meet its target outcome of progression-free survival.
July 14, 2020
Junshi Completes Enrollment for Phase 1 Trial of COVID-19 Antibody
Shanghai-based Junshi Biosciences announced that it has finished enrolling participants in a phase 1 trial of JS016, its COVID-19 neutralizing antibody.

July 13, 2020
New Data Shows Gilead’s Remdesivir Improves Recovery for COVID-19 Patients
July 13, 2020
Gilead Says Remdesivir Reduced Mortality in COVID-19 Patients
July 10, 2020
Gilead Sciences Kicks Off Phase 1 Trial of Inhaled Remdesivir for COVID-19
July 10, 2020
Pharma Companies Launch $1 Billion Program to Develop New Antibiotics
July 10, 2020
Gilead Sciences Launches Early Trial of Inhaled Remdesivir for COVID-19

July 9, 2020
UK Launches New Trial Platform to Accelerate COVID-19 Treatments
July 9, 2020
Clover Biopharmaceuticals Gets $66 Million from CEPI for COVID-19 Vaccine Trial
July 9, 2020
New NIH Network to Coordinate Multiple COVID-19 Vaccine Trials
July 9, 2020
Merck, Eisai Hit With CRL for Keytruda-Lenvima Combo
July 9, 2020
Clover Biopharmaceuticals Gets $66 Million From CEPI for COVID-19 Vaccine Trial

Pages